It depends on the terms of whatever contract a com
Post# of 72440
(Total Views: 249)
Posted On: 03/25/2018 10:52:34 AM
It depends on the terms of whatever contract a company signs with a clinical trial site. I suppose a company could try to build in some kind of penalties for not providing data. Each situation is going to be different.
However, a clinical trial site that is super slow is not going to get a company's business a second time, and will get a reputation for being slow. Exhibit A: IPIX is not doing the Kevetrin trial at Dana-Farber any more, even though DF wanted to continue. They were incredibly slow. So, they're out of the loop now.
However, a clinical trial site that is super slow is not going to get a company's business a second time, and will get a reputation for being slow. Exhibit A: IPIX is not doing the Kevetrin trial at Dana-Farber any more, even though DF wanted to continue. They were incredibly slow. So, they're out of the loop now.
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼